Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease
Background. Midkine (MK), a new heparin-binding growth factor, plays important roles in a variety of biological phenomena such as carcinogenesis, inflammation, and angiogenesis. In this study, we aimed to evaluate serum midkine (SMK) and nodular midkine (NMK) levels in patients with thyroid nodules...
Saved in:
Main Authors: | Fatih Kuzu, Dilek Arpaci, Mustafa Unal, Ayfer Altas, Gürkan Haytaoglu, Murat Can, Figen Barut, Furuzan Kokturk, Sevil Uygun Ilikhan, Taner Bayraktaroglu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/6035024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinical Values of Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Blood and Thyroid Nodules
by: Ayfer Altas, et al.
Published: (2017-01-01) -
Midkine Is a Novel Regulator of Amphetamine-Induced Striatal Gliosis and Cognitive Impairment: Evidence for a Stimulus-Dependent Regulation of Neuroinflammation by Midkine
by: Marta Vicente-Rodríguez, et al.
Published: (2016-01-01) -
The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma
by: Karim Y. A. Shaheen, et al.
Published: (2015-01-01) -
The Impact of Obstructive Sleep Apnoea and Nasal Continuous Positive Airway Pressure on Circulating Ischaemia-Modified Albumin Concentrations
by: Firat Uygur, et al.
Published: (2016-01-01) -
Nodular Elastosis of the Pancreas
by: Whitney Wedel, et al.
Published: (2015-01-01)